Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3338315rdf:typepubmed:Citationlld:pubmed
pubmed-article:3338315lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:3338315lifeskim:mentionsumls-concept:C0002598lld:lifeskim
pubmed-article:3338315lifeskim:mentionsumls-concept:C0149726lld:lifeskim
pubmed-article:3338315lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:3338315lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:3338315lifeskim:mentionsumls-concept:C0449450lld:lifeskim
pubmed-article:3338315pubmed:issue2lld:pubmed
pubmed-article:3338315pubmed:dateCreated1988-3-10lld:pubmed
pubmed-article:3338315pubmed:abstractTextFollowing treatment with amiodarone, a patient developed weight loss, fatigue and severe myopathy, without respiratory symptoms. A solitary lung infiltrate, impaired thyroid and liver function tests, and leukocytosis were evident. Biopsies from the lung lesion, liver, and bone marrow revealed foam cells. All these signs and symptoms subsided following cessation of amiodarone therapy. It is demonstrated that amiodarone may induce a localized lung lesion rather than diffuse pulmonary disease.lld:pubmed
pubmed-article:3338315pubmed:languageenglld:pubmed
pubmed-article:3338315pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3338315pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3338315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3338315pubmed:statusMEDLINElld:pubmed
pubmed-article:3338315pubmed:monthFeblld:pubmed
pubmed-article:3338315pubmed:issn0012-3692lld:pubmed
pubmed-article:3338315pubmed:authorpubmed-author:ArnonRRlld:pubmed
pubmed-article:3338315pubmed:authorpubmed-author:Bar-OnHHlld:pubmed
pubmed-article:3338315pubmed:authorpubmed-author:RaoBBlld:pubmed
pubmed-article:3338315pubmed:authorpubmed-author:BerkmanNNlld:pubmed
pubmed-article:3338315pubmed:authorpubmed-author:FieldsSSlld:pubmed
pubmed-article:3338315pubmed:authorpubmed-author:Chajek-ShaulT...lld:pubmed
pubmed-article:3338315pubmed:issnTypePrintlld:pubmed
pubmed-article:3338315pubmed:volume93lld:pubmed
pubmed-article:3338315pubmed:ownerNLMlld:pubmed
pubmed-article:3338315pubmed:authorsCompleteYlld:pubmed
pubmed-article:3338315pubmed:pagination425-7lld:pubmed
pubmed-article:3338315pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3338315pubmed:meshHeadingpubmed-meshheading:3338315-...lld:pubmed
pubmed-article:3338315pubmed:meshHeadingpubmed-meshheading:3338315-...lld:pubmed
pubmed-article:3338315pubmed:meshHeadingpubmed-meshheading:3338315-...lld:pubmed
pubmed-article:3338315pubmed:meshHeadingpubmed-meshheading:3338315-...lld:pubmed
pubmed-article:3338315pubmed:meshHeadingpubmed-meshheading:3338315-...lld:pubmed
pubmed-article:3338315pubmed:year1988lld:pubmed
pubmed-article:3338315pubmed:articleTitleAmiodarone pulmonary toxicity presenting as a solitary lung mass.lld:pubmed
pubmed-article:3338315pubmed:affiliationDepartment of Medicine B, Hadassah University Hospital, Jerusalem, Israel.lld:pubmed
pubmed-article:3338315pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3338315pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3338315lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3338315lld:pubmed